Laboratory and Research Center (“AMARC”). Costs and Expenses The Company reported the consolidated costs and expenses for Q1/2019 of Baht 345.54 million, nearby of Q1/2018 of Baht 345.61 million decreased by
booked in year 2018 for chronic diseases were then subtracted accordingly. However, the service revenues (mainly received from Asia Medical and Agricultural Laboratory and Research Center Co., Ltd “AMARC
to the hospital. In regard to the subsidiary, Asia Medical & Agricultural Laboratory and Research Center (“AMARC”), its service revenues grew by 12.60% as it provides laboratory testing and analyzing
Exchange of Thailand. The papers pointed out the significance of making prudent study on information and fundamental analysis of securities prior to making investment decision in order to mitigate trading
retirement?. Presented at the Forum were the study on major exchange volatilities which are interrelated during the crisis and the study allocation of investment suggesting that starting plan for retirement
Laboratory and Research Center (“AMARC”), a subsidiary, recorded a 21.02% growth of service revenues totaling Baht 197.75 million over same period of 2018. Costs and Expenses The Company reported 2019
เอ็นจิเนียริ่ง เน็ตเวิร์ค จำกัด (มหาชน) กรุณาระบุเงื่อนไขในการค้นหา ค้นหาบริษัท AMARC: ASIA MEDICAL AND AGRICULTURAL LABORATORY AND RESEARCH CENTER PUBLIC COMPANY LIMITED CEN: บริษัท แคปปิทอล เอ็นจิเนีย
NETWORK PUBLIC COMPANY LIMITED Please enter search criteria Search Company AMARC: ASIA MEDICAL AND AGRICULTURAL LABORATORY AND RESEARCH CENTER PUBLIC COMPANY LIMITED CEN: CAPITAL ENGINEERING NETWORK PUBLIC
LABORATORY AND RESEARCH CENTER PUBLIC COMPANY LIMITED / ASIA MEDICAL AND AGRICULTURAL LABORATORY AND RESEARCH CENTER PUBLIC COMPANY LIMITED Common share IPO CHIN HUAY PUBLIC COMPANY LIMITED / CHIN HUAY
presented the papers on ?Listed Company Assessment?. The first study showed a forecasting model developed to predict the listed companies? conditions, resulting in the same direction as credit rating